Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35,374 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized phase I clinical trial comparing the pharmacokinetic, safety, and immunogenicity of potential biosimilar recombinant human HER2 monoclonal antibody for injection and trastuzumab in healthy Chinese adults.
Wang J, Niu S, Dong W, Wei L, Ou L, Zhang T, Zhang L, Nie X, Wang Q, Shen T, Wang Q, Xia L, Liu G, Jin J, Zheng Q, Song H, Fang Y. Wang J, et al. Among authors: liu g. Expert Opin Investig Drugs. 2020 Jul;29(7):755-762. doi: 10.1080/13543784.2020.1770226. Epub 2020 Jun 27. Expert Opin Investig Drugs. 2020. PMID: 32594779 Clinical Trial.
Pharmacokinetic bioequivalence, safety, and immunogenicity of GB222, a bevacizumab biosimilar candidate, and bevacizumab in Chinese healthy males: a randomized clinical trial.
Dong W, Chen M, Niu S, Wang B, Xia L, Wang J, Shen T, Wang Q, Lv J, Liu G, Fan H, Xie Z, Xie F, An Y, Zheng Q, Rao H, Song H, Fang Y. Dong W, et al. Among authors: liu g. Expert Opin Biol Ther. 2022 Feb;22(2):253-262. doi: 10.1080/14712598.2021.1954157. Epub 2021 Jul 26. Expert Opin Biol Ther. 2022. PMID: 34236011 Clinical Trial.
A Randomized Controlled Dose-Escalation Study of LY06006, a Recombinant Humanized Monoclonal Antibody to RANKL, in Chinese Healthy Adults.
Niu S, Chen M, Yan D, Liu X, Guo S, Ou L, Fan H, Lv J, Wang Q, Dong W, Xia L, Wang S, Liu G, Gu Q, Guo D, Liu H, Rao H, Zheng Q, Nie X, Song H, Fang Y. Niu S, et al. Among authors: liu x, liu h, liu g. Front Pharmacol. 2022 Jun 15;13:893166. doi: 10.3389/fphar.2022.893166. eCollection 2022. Front Pharmacol. 2022. PMID: 35784742 Free PMC article.
Pharmacokinetics, pharmacodynamics, safety, and immunogenicity of Gerilimzumab (GB224), a recombinant humanized interleukin-6 monoclonal antibody, in healthy Chinese adults: A randomized controlled dose-escalation study.
Yan D, Niu S, Hu D, Dong W, Sun Y, Wang Q, Wang S, Gu Q, Liu G, Wang J, Chen L, Lv J, Zheng Q, Song H, Fang Y. Yan D, et al. Among authors: liu g. Expert Opin Investig Drugs. 2023 Feb;32(2):161-170. doi: 10.1080/13543784.2023.2178894. Epub 2023 Feb 20. Expert Opin Investig Drugs. 2023. PMID: 36755413 Clinical Trial.
Effect of mild hypothermia vs normothermia cardiopulmonary bypass on postoperative bleeding in patients undergoing coronary artery bypass grafting: protocol of a multi-center, randomized, controlled trial.
Wang J, Wang T, Zhang H, Zhang Q, Liu G, Yan S, Wang Q, Teng Y, Wang J, Hu Q, Ji B. Wang J, et al. Among authors: liu g. BMC Surg. 2024 Oct 22;24(1):323. doi: 10.1186/s12893-024-02634-6. BMC Surg. 2024. PMID: 39438868 Free PMC article. Clinical Trial.
35,374 results
You have reached the last available page of results. Please see the User Guide for more information.